Harding Loevner LP Genmab A/S Transaction History

Harding Loevner LP

$17.1 Billion
Q3 2024

A detailed history of Harding Loevner LP transactions in Genmab A/S stock. As of the latest transaction made, Harding Loevner LP holds 3,066,942 shares of GMAB stock, worth $63.1 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,066,942

Previous 2,767,805 10.81%

Holding current value

$63.1 Million

Previous $69.6 Million 7.5%

% of portfolio

0.44%

Previous 0.4%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.84 - $28.48 $7.13 Million - $8.52 Million	299,137 Added 10.81%	3,066,942 $74.8 Million
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $13.2 Million - $15.9 Million	-526,923 Reduced 15.99%	2,767,805 $69.6 Million
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $127,736 - $158,377	4,833 Added 0.15%	3,294,728 $98.5 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $2.39 Million - $3.04 Million	85,665 Added 2.67%	3,289,895 $105 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $107 Million - $128 Million	3,036,109 Added 1805.91%	3,204,230 $113 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $75,884 - $87,125	-2,029 Reduced 1.19%	168,121 $6.39 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $1.65 Million - $2.04 Million	47,238 Added 38.43%	170,150 $6.42 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $213,210 - $296,854	-6,308 Reduced 4.88%	122,912 $5.21 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $33,442 - $396,400	-1,061 Reduced 0.81%	129,220 $4.15 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $178,875 - $257,146	-6,667 Reduced 4.87%	130,281 $4.24 Million
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $56,545 - $72,495	1,827 Added 1.35%	136,948 $4.96 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $111,125 - $145,977	3,098 Added 2.35%	135,121 $5.35 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $11,093 - $13,008	-267 Reduced 0.2%	132,023 $5.77 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $427,834 - $579,944	13,012 Added 10.91%	132,290 $5.4 Million
Q1 2021 May 17, 2021	SELL	$30.92 - $44.4 $156,146 - $224,220	-5,050 Reduced 4.06%	119,278 $3.92 Million
Q4 2020 Feb 16, 2021	BUY	$33.66 - $40.76 $4.18 Million - $5.07 Million	124,328 New	124,328 $5.06 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account

Harding Loevner LP Genmab A/S Transaction History